PCSK1N and synucleinopathy: Advances in detecting α-synuclein pathology through in vivo α-syn SAAs must be anchored in neuropathological studies, which define the biological basis of synucleinopathies, elucidate the role of co-pathologies, and reveal critical insights into the anatomical and structural diversity of α-synuclein aggregates.7